Susceptibility to Low Vitamin B6 Diet–induced Gestational Diabetes Is Modulated by Strain Differences in Mice
Endocrinology · 28.08.2023 · 164 (10)
DOI: 10.1210/endocr/bqad130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 25.08.2023. Verfasst von Philip Spinelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. Hauptthemen laut MEDLINE: Diabetes, Gestational, Glucose Intolerance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes is a common pregnancy complication that adversely influences the health and survival of mother and child. Pancreatic islet serotonin signaling plays an important role in β-cell proliferation in pregnancy, and environmental and genetic factors that disrupt serotonin signaling are associated with gestational diabetes in mice. Our previous studies show that pregnant C57BL/6J mice fed a diet that is low in vitamin B6, a critical co-factor in serotonin synthesis, develop hyperglycemia and glucose intolerance, phenotypes that are consistent with gestational diabetes in humans. The current study shows that, unlike in the C57BL/6J mice, low vitamin B6 diet does not alter glucose tolerance and insulin secretion in pregnant DBA/2J mice. The hypothesis to be tested in the current study is that pregnant DBA/2J mice are protected against low vitamin B6–induced gestational diabetes due to their higher expression and enzymatic activities of tissue nonspecific alkaline phosphatase (ALPL) relative to C57BL/6J. ALPL is a rate-limiting enzyme that regulates vitamin B6 bioavailability. Interestingly, treating pregnant DBA/2J mice with 7.5 mg/kg/day of the ALPL inhibitor SBI-425 is associated with glucose intolerance in low vitamin B6–fed mice, implying that inhibition of ALPL activity is sufficient to modulate resilience to low vitamin B6–induced metabolic impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
- Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
ORCID-Profile: Martha Susiarjo
Förderung
- NIEHS NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- University of Rochester
Zitieren
APA
Spinelli, P., Fields, A. M., Falcone, S., Mesaros, C., & Susiarjo, M. (2023). Susceptibility to Low Vitamin B6 Diet–induced Gestational Diabetes Is Modulated by Strain Differences in Mice. Endocrinology, 164(10). https://doi.org/10.1210/endocr/bqad130
Vancouver
Spinelli P, Fields AM, Falcone S, Mesaros C, Susiarjo M. Susceptibility to Low Vitamin B6 Diet–induced Gestational Diabetes Is Modulated by Strain Differences in Mice. Endocrinology. 2023;164(10). doi:10.1210/endocr/bqad130
BibTeX
@article{Spinelli2023,
author = {Spinelli, Philip and Fields, Ashley M and Falcone, Sierra and Mesaros, Clementina and Susiarjo, Martha},
title = {Susceptibility to Low Vitamin B6 Diet–induced Gestational Diabetes Is Modulated by Strain Differences in Mice},
journal = {Endocrinology},
year = {2023},
volume = {164},
number = {10},
doi = {10.1210/endocr/bqad130}
}
EUVIMED